Bibliography For Cerebrolysin

Every Curated Peer-Reviewed Reference Indexed For This Compound. Each Citation Can Be Exported In BibTeX, RIS, EndNote, Or Plain Text.

Indexed Types:study

n.d. - study

Combined citicoline and Cerebrolysin for neuroprotection in traumatic brain injury: a retrospective cohort analysis.

Unknown Authors.

n.d. - study

Surgical excision of cerebral glioma and multimodal treatment including Cerebrolysin: a case report.

Unknown Authors.

n.d. - study

The Role of Cerebrolysin in Promoting Axonal Regeneration and Functional Recovery after Peripheral Nerve Injury: A Focus on Macrophage Activation.

Unknown Authors.

n.d. - study

Safety and feasibility of cerebrolysin in treatment of primary intracerebral hemorrhage (CLINCH)-a prospective, randomized, open-label, blinded endpoint pilot trial.

Unknown Authors.

n.d. - study

Cerebrolysin treatment in a case of post-herpes simplex encephalitis with neuropsychiatric symptoms.

Unknown Authors.

n.d. - study

C-REGS2-A multinational, high-quality comparative effectiveness study of Cerebrolysin in moderate acute ischemic stroke.

Unknown Authors.

n.d. - study

Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study.

Unknown Authors.

n.d. - study

Safety and Efficacy of Cerebrolysin for Neurorecovery After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of 14 Randomized Controlled Trials.

Unknown Authors.

n.d. - study

Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via modulation of mitochondrial function and CREB/PGC-1α pathway.

Unknown Authors.

n.d. - study

Is Cerebrolysin Useful in Psychiatry Disorders?

Unknown Authors.

n.d. - study

ABSTRACT NUMBER: ESOC2026A562 CEREBROLYSIN AFTER ENDOVASCULAR THROMBECTOMY IN STROKE: 12-MONTH FUNCTIONAL OUTCOMES IN A PROPENSITY-MATCHED COHORT

Unknown Authors.

n.d. - study

Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothelial Cell Permeability.

Unknown Authors.

n.d. - study

ABSTRACT NUMBER: ESOC2026A822 VIRTUAL REALITY NEURORREHABILITATION IN ACUTE STROKE PATIENTS AND THE ADD-ON EFFECT OF CEREBROLYSIN

Unknown Authors.

n.d. - study

ABSTRACT NUMBER: ESOC2026A102 META-ANALYSIS: THE EFFECT OF CEREBROLYSIN COMBINED WITH SPEECH THERAPY ON NONFLUENT APHASIA RECOVERY AFTER ISCHEMIC STROKE

Unknown Authors.

n.d. - study

ABSTRACT NUMBER: ESOC2026A632 CYTOPROTECTIVE EFFICACY OF CEREBROLYSIN IN PATIENTS WITH RESIDUAL POST-THROMBECTOMY PERFUSION DEFICITS: A PROOF-OF-CONCEPT STUDY

Unknown Authors.

n.d. - study

Biochemical and Pharmacological Studies on Kynurenic Acid Metabolism in the <i>Helix pomatia</i>-Snail Model of Learning and Memory.

Unknown Authors.

n.d. - study

ABSTRACT NUMBER: ESOC2026A160 IMPROVED COGNITIVE TRAJECTORY AFTER ACUTE ISCHEMIC STROKE: INSIGHTS FROM C-REGS2 TRIAL

Unknown Authors.

n.d. - study

Efficacy and Safety of Cerebrolysin as an Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Observational Studies.

Unknown Authors.

n.d. - study

Cerebrolysin after Endovascular Thrombectomy in Stroke: 12‑Month Functional Outcomes in a Propensity‑Matched Cohort.

Unknown Authors.

n.d. - study

Cerebrolysin and Risk of Hemorrhagic Transformation: A Pooled Analysis of Recent Studies.

Unknown Authors.

n.d. - study

Retraction Note: Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-Spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50-60 nm) Nanoparticles.

Unknown Authors.

n.d. - study

Cerebrolysin, hemorrhagic transformation, and anticoagulation timing after reperfusion therapy in stroke: <i>post hoc</i> secondary analysis of the CEREHETIS trial.

Unknown Authors.

n.d. - study

ABSTRACT NUMBER: ESOC2026A818 THE HOMEOSTASIS-BASED PROTOCOL TO FREEZE PENUMBRA IN ISCHEMIC STROKE PATIENTS

Unknown Authors.

n.d. - study

Neuroprotective Effects of Cerebrolysin in Moderate Traumatic Brain Injury with Nonoperative Lesions: A 6-Month Prospective Cohort Analysis.

Unknown Authors.

n.d. - study

ABSTRACT NUMBER: ESOC2026A2077 NEUROD AND NNT1 AS PREDICTORS OF THE OUTCOMES IN ACUTE ISCHEMIC STROKE PATIENTS UNDERGOING MECHANICAL THROMBECTOMY

Unknown Authors.

Combined citicoline and Cerebrolysin for neuroprotection in traumatic brain injury: a retrospective cohort analysis.

Surgical excision of cerebral glioma and multimodal treatment including Cerebrolysin: a case report.

The Role of Cerebrolysin in Promoting Axonal Regeneration and Functional Recovery after Peripheral Nerve Injury: A Focus on Macrophage Activation.

Safety and feasibility of cerebrolysin in treatment of primary intracerebral hemorrhage (CLINCH)-a prospective, randomized, open-label, blinded endpoint pilot trial.

Cerebrolysin treatment in a case of post-herpes simplex encephalitis with neuropsychiatric symptoms.

C-REGS2-A multinational, high-quality comparative effectiveness study of Cerebrolysin in moderate acute ischemic stroke.

Evaluating the Effect of Cerebrolysin as an Adjuvant to Standard Therapy in Patients with Acute Ischemic Stroke: A Prospective Observational Study.

Safety and Efficacy of Cerebrolysin for Neurorecovery After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of 14 Randomized Controlled Trials.

Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via modulation of mitochondrial function and CREB/PGC-1α pathway.

Is Cerebrolysin Useful in Psychiatry Disorders?

ABSTRACT NUMBER: ESOC2026A562 CEREBROLYSIN AFTER ENDOVASCULAR THROMBECTOMY IN STROKE: 12-MONTH FUNCTIONAL OUTCOMES IN A PROPENSITY-MATCHED COHORT

Exosomes Released by Cerebrolysin-Treated Cerebral Endothelial Cells Reverse Fibrin- or tPA-Impaired Endothelial Cell Permeability.

ABSTRACT NUMBER: ESOC2026A822 VIRTUAL REALITY NEURORREHABILITATION IN ACUTE STROKE PATIENTS AND THE ADD-ON EFFECT OF CEREBROLYSIN

ABSTRACT NUMBER: ESOC2026A102 META-ANALYSIS: THE EFFECT OF CEREBROLYSIN COMBINED WITH SPEECH THERAPY ON NONFLUENT APHASIA RECOVERY AFTER ISCHEMIC STROKE

ABSTRACT NUMBER: ESOC2026A632 CYTOPROTECTIVE EFFICACY OF CEREBROLYSIN IN PATIENTS WITH RESIDUAL POST-THROMBECTOMY PERFUSION DEFICITS: A PROOF-OF-CONCEPT STUDY

Biochemical and Pharmacological Studies on Kynurenic Acid Metabolism in the &lt;i&gt;Helix pomatia&lt;/i&gt;-Snail Model of Learning and Memory.

ABSTRACT NUMBER: ESOC2026A160 IMPROVED COGNITIVE TRAJECTORY AFTER ACUTE ISCHEMIC STROKE: INSIGHTS FROM C-REGS2 TRIAL

Efficacy and Safety of Cerebrolysin as an Adjunct to Mechanical Thrombectomy in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Observational Studies.

Cerebrolysin after Endovascular Thrombectomy in Stroke: 12‑Month Functional Outcomes in a Propensity‑Matched Cohort.

Cerebrolysin and Risk of Hemorrhagic Transformation: A Pooled Analysis of Recent Studies.

Retraction Note: Cerebrolysin Attenuates Exacerbation of Neuropathic Pain, Blood-Spinal Cord Barrier Breakdown and Cord Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50-60 nm) Nanoparticles.

Cerebrolysin, hemorrhagic transformation, and anticoagulation timing after reperfusion therapy in stroke: &lt;i&gt;post hoc&lt;/i&gt; secondary analysis of the CEREHETIS trial.

ABSTRACT NUMBER: ESOC2026A818 THE HOMEOSTASIS-BASED PROTOCOL TO FREEZE PENUMBRA IN ISCHEMIC STROKE PATIENTS

Neuroprotective Effects of Cerebrolysin in Moderate Traumatic Brain Injury with Nonoperative Lesions: A 6-Month Prospective Cohort Analysis.

ABSTRACT NUMBER: ESOC2026A2077 NEUROD AND NNT1 AS PREDICTORS OF THE OUTCOMES IN ACUTE ISCHEMIC STROKE PATIENTS UNDERGOING MECHANICAL THROMBECTOMY

Biochemical and Pharmacological Studies on Kynurenic Acid Metabolism in the <i>Helix pomatia</i>-Snail Model of Learning and Memory.

Cerebrolysin, hemorrhagic transformation, and anticoagulation timing after reperfusion therapy in stroke: <i>post hoc</i> secondary analysis of the CEREHETIS trial.